Cargando…

The role of cortisol in ischemic heart disease, ischemic stroke, type 2 diabetes, and cardiovascular disease risk factors: a bi-directional Mendelian randomization study

BACKGROUND: Cortisol, a steroid hormone frequently used as a biomarker of stress, is associated with cardiovascular disease (CVD) and type 2 diabetes mellitus (T2DM). To clarify whether cortisol causes these outcomes, we assessed the role of cortisol in ischemic heart disease (IHD), ischemic stroke,...

Descripción completa

Detalles Bibliográficos
Autores principales: Kwok, Man Ki, Kawachi, Ichiro, Rehkopf, David, Schooling, Catherine Mary
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7694946/
https://www.ncbi.nlm.nih.gov/pubmed/33243239
http://dx.doi.org/10.1186/s12916-020-01831-3
_version_ 1783615087161901056
author Kwok, Man Ki
Kawachi, Ichiro
Rehkopf, David
Schooling, Catherine Mary
author_facet Kwok, Man Ki
Kawachi, Ichiro
Rehkopf, David
Schooling, Catherine Mary
author_sort Kwok, Man Ki
collection PubMed
description BACKGROUND: Cortisol, a steroid hormone frequently used as a biomarker of stress, is associated with cardiovascular disease (CVD) and type 2 diabetes mellitus (T2DM). To clarify whether cortisol causes these outcomes, we assessed the role of cortisol in ischemic heart disease (IHD), ischemic stroke, T2DM, and CVD risk factors using a bi-directional Mendelian randomization (MR) study. METHODS: Single nucleotide polymorphisms (SNPs) strongly (P < 5 × 10(−6)) and independently (r(2) < 0.001) predicting cortisol were obtained from the CORtisol NETwork (CORNET) consortium (n = 12,597) and two metabolomics genome-wide association studies (GWAS) (n = 7824 and n = 2049). They were applied to GWAS of the primary outcomes (IHD, ischemic stroke and T2DM) and secondary outcomes (adiposity, glycemic traits, blood pressure and lipids) to obtain estimates using inverse variance weighting, with weighted median, MR-Egger, and MR-PRESSO as sensitivity analyses. Conversely, SNPs predicting IHD, ischemic stroke, and T2DM were applied to the cortisol GWAS. RESULTS: Genetically predicted cortisol (based on 6 SNPs from CORNET; F-statistic = 28.3) was not associated with IHD (odds ratio (OR) 0.98 per 1 unit increase in log-transformed cortisol, 95% confidence interval (CI) 0.93–1.03), ischemic stroke (0.99, 95% CI 0.91–1.08), T2DM (1.00, 95% CI 0.96–1.04), or CVD risk factors. Genetically predicted IHD, ischemic stroke, and T2DM were not associated with cortisol. CONCLUSIONS: Contrary to observational studies, genetically predicted cortisol was unrelated to IHD, ischemic stroke, T2DM, or CVD risk factors, or vice versa. Our MR results find no evidence that cortisol plays a role in cardiovascular risk, casting doubts on the cortisol-related pathway, although replication is warranted. SUPPLEMENTARY INFORMATION: Supplementary information accompanies this paper at 10.1186/s12916-020-01831-3.
format Online
Article
Text
id pubmed-7694946
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-76949462020-11-30 The role of cortisol in ischemic heart disease, ischemic stroke, type 2 diabetes, and cardiovascular disease risk factors: a bi-directional Mendelian randomization study Kwok, Man Ki Kawachi, Ichiro Rehkopf, David Schooling, Catherine Mary BMC Med Research Article BACKGROUND: Cortisol, a steroid hormone frequently used as a biomarker of stress, is associated with cardiovascular disease (CVD) and type 2 diabetes mellitus (T2DM). To clarify whether cortisol causes these outcomes, we assessed the role of cortisol in ischemic heart disease (IHD), ischemic stroke, T2DM, and CVD risk factors using a bi-directional Mendelian randomization (MR) study. METHODS: Single nucleotide polymorphisms (SNPs) strongly (P < 5 × 10(−6)) and independently (r(2) < 0.001) predicting cortisol were obtained from the CORtisol NETwork (CORNET) consortium (n = 12,597) and two metabolomics genome-wide association studies (GWAS) (n = 7824 and n = 2049). They were applied to GWAS of the primary outcomes (IHD, ischemic stroke and T2DM) and secondary outcomes (adiposity, glycemic traits, blood pressure and lipids) to obtain estimates using inverse variance weighting, with weighted median, MR-Egger, and MR-PRESSO as sensitivity analyses. Conversely, SNPs predicting IHD, ischemic stroke, and T2DM were applied to the cortisol GWAS. RESULTS: Genetically predicted cortisol (based on 6 SNPs from CORNET; F-statistic = 28.3) was not associated with IHD (odds ratio (OR) 0.98 per 1 unit increase in log-transformed cortisol, 95% confidence interval (CI) 0.93–1.03), ischemic stroke (0.99, 95% CI 0.91–1.08), T2DM (1.00, 95% CI 0.96–1.04), or CVD risk factors. Genetically predicted IHD, ischemic stroke, and T2DM were not associated with cortisol. CONCLUSIONS: Contrary to observational studies, genetically predicted cortisol was unrelated to IHD, ischemic stroke, T2DM, or CVD risk factors, or vice versa. Our MR results find no evidence that cortisol plays a role in cardiovascular risk, casting doubts on the cortisol-related pathway, although replication is warranted. SUPPLEMENTARY INFORMATION: Supplementary information accompanies this paper at 10.1186/s12916-020-01831-3. BioMed Central 2020-11-27 /pmc/articles/PMC7694946/ /pubmed/33243239 http://dx.doi.org/10.1186/s12916-020-01831-3 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Kwok, Man Ki
Kawachi, Ichiro
Rehkopf, David
Schooling, Catherine Mary
The role of cortisol in ischemic heart disease, ischemic stroke, type 2 diabetes, and cardiovascular disease risk factors: a bi-directional Mendelian randomization study
title The role of cortisol in ischemic heart disease, ischemic stroke, type 2 diabetes, and cardiovascular disease risk factors: a bi-directional Mendelian randomization study
title_full The role of cortisol in ischemic heart disease, ischemic stroke, type 2 diabetes, and cardiovascular disease risk factors: a bi-directional Mendelian randomization study
title_fullStr The role of cortisol in ischemic heart disease, ischemic stroke, type 2 diabetes, and cardiovascular disease risk factors: a bi-directional Mendelian randomization study
title_full_unstemmed The role of cortisol in ischemic heart disease, ischemic stroke, type 2 diabetes, and cardiovascular disease risk factors: a bi-directional Mendelian randomization study
title_short The role of cortisol in ischemic heart disease, ischemic stroke, type 2 diabetes, and cardiovascular disease risk factors: a bi-directional Mendelian randomization study
title_sort role of cortisol in ischemic heart disease, ischemic stroke, type 2 diabetes, and cardiovascular disease risk factors: a bi-directional mendelian randomization study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7694946/
https://www.ncbi.nlm.nih.gov/pubmed/33243239
http://dx.doi.org/10.1186/s12916-020-01831-3
work_keys_str_mv AT kwokmanki theroleofcortisolinischemicheartdiseaseischemicstroketype2diabetesandcardiovasculardiseaseriskfactorsabidirectionalmendelianrandomizationstudy
AT kawachiichiro theroleofcortisolinischemicheartdiseaseischemicstroketype2diabetesandcardiovasculardiseaseriskfactorsabidirectionalmendelianrandomizationstudy
AT rehkopfdavid theroleofcortisolinischemicheartdiseaseischemicstroketype2diabetesandcardiovasculardiseaseriskfactorsabidirectionalmendelianrandomizationstudy
AT schoolingcatherinemary theroleofcortisolinischemicheartdiseaseischemicstroketype2diabetesandcardiovasculardiseaseriskfactorsabidirectionalmendelianrandomizationstudy
AT kwokmanki roleofcortisolinischemicheartdiseaseischemicstroketype2diabetesandcardiovasculardiseaseriskfactorsabidirectionalmendelianrandomizationstudy
AT kawachiichiro roleofcortisolinischemicheartdiseaseischemicstroketype2diabetesandcardiovasculardiseaseriskfactorsabidirectionalmendelianrandomizationstudy
AT rehkopfdavid roleofcortisolinischemicheartdiseaseischemicstroketype2diabetesandcardiovasculardiseaseriskfactorsabidirectionalmendelianrandomizationstudy
AT schoolingcatherinemary roleofcortisolinischemicheartdiseaseischemicstroketype2diabetesandcardiovasculardiseaseriskfactorsabidirectionalmendelianrandomizationstudy